As of Nov 27
| +0.09 / +0.23%|
The 4 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 43.00, with a high estimate of 48.00 and a low estimate of 39.00. The median estimate represents a +11.72% increase from the last price of 38.49.
The current consensus among 4 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.